Clinical Developments for AXN-2510/IMM2510 in NSCLC Show Promise
March 4, 2025 - 12:22
Recent updates have highlighted significant advancements in the clinical development of AXN-2510/IMM2510, particularly in the treatment of relapsed and refractory non-small cell lung cancer (NSCLC) in China. ImmuneOnco is expected to release clinical data related to the monotherapy of AXN-2510/IMM2510 in the first half of 2025. This data is eagerly anticipated as it could provide valuable insights into the efficacy of the treatment.
Furthermore, the enrollment of patients with first-line NSCLC for a trial combining AXN-2510/IMM2510 with chemotherapy is projected to begin in the second quarter of 2025. Initial clinical results from this trial are expected to be available in the latter half of 2025, potentially paving the way for new treatment protocols.
In addition, plans are underway to initiate a U.S. clinical study of AXN-2510/IMM2510 in conjunction with chemotherapy for first-line NSCLC patients, with expectations for this to commence before the end of the year. These developments reflect a growing commitment to advancing therapies for NSCLC and improving patient outcomes.
MORE NEWS
September 23, 2025 - 10:20
Nebraska Commission Aims for Stability in School FundingA newly established commission in Nebraska is focusing on providing sustainable solutions for the funding of public schools, with an emphasis on achieving greater stability and predictability in...
September 22, 2025 - 18:37
Essential Tips for Choosing the Right Financial Advisor: What to Watch Out ForFinding the right advisor is key to your long-term financial wellbeing. When selecting a financial advisor, it`s crucial to be aware of potential red flags that could indicate a poor fit for your...
September 22, 2025 - 00:29
Transform Your Finances with a 12-Week Reset PlanA new 12-week financial reset program has emerged, designed to assist individuals in taking control of their financial health. This structured plan aims to help Americans tackle debt, reduce...
September 21, 2025 - 04:16
Investors Outraged Over Tenant's Controversial Request for Personal InformationIn a surprising turn of events, landlords across Australia are expressing their outrage over a tenant`s request for personal information. The demand has ignited a heated debate about the rights of...